|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows From Operating Activities | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||||
| Depreciation and amortization of intangible assets | |||||
| Amortization and write-off of debt discounts and debt issuance costs | |||||
| Asset impairments | |||||
| Goodwill impairment | |||||
| Acquisition-related contingent consideration | |||||
| Allowances for losses on trade receivables and inventories | |||||
| Deferred income taxes | |||||
| Net gain on sale of assets | |||||
| Additions to accrued legal settlements | |||||
| Payments of accrued legal settlements | |||||
| Share-based compensation | |||||
| Gain excluded from hedge effectiveness | |||||
| Third party fees paid in connection with the 2022 Exchange | |||||
| Payments of contingent consideration adjustments, including accretion | |||||
| Amortization of inventory step-up resulting from acquisitions | |||||
| Foreign exchange and other | |||||
| Changes in operating assets and liabilities: | |||||
| Trade receivables | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable, accrued and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash Flows From Investing Activities | |||||
| Acquisitions and other investments | |||||
| Purchases of property, plant and equipment | |||||
| Acquisition of intangible assets and other assets | |||||
| Purchases of marketable securities | |||||
| Proceeds from sale of marketable securities | |||||
| Proceeds from sale of assets and businesses, net of costs to sell | |||||
| Interest settlements from cross-currency swaps | |||||
| Net cash used in investing activities | |||||
| Cash Flows From Financing Activities | |||||
| Issuance of long-term debt, net of discounts | |||||
| Repayments of long-term debt | |||||
| Proceeds from B+L initial public offering, net of costs | |||||
| Payment of employee withholding taxes related to share-based awards | |||||
| Payments of acquisition-related contingent consideration | |||||
| Payments of financing costs | |||||
| Other | |||||
| Net cash (used in) provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of year | |||||
| Cash, cash equivalents and restricted cash, end of year | |||||
| Cash and cash equivalents, end of year | |||||
| Restricted cash, end of year | |||||
Loading...